1.1 TCQR Pathway and PSI Equivalence Exam Structure

1.1 TCQR Pathway and PSI Equivalence Exam Structure

Statutory Notice: Pharmacists qualifying outside the European Union (EU) or European Economic Area (EEA) must successfully navigate the Third Country Qualification Recognition (TCQR) process administered by the Pharmaceutical Society of Ireland (PSI) pursuant to the Pharmacy Act 2007 before applying for entry onto the Register of Pharmacists in Ireland.

The Pharmaceutical Society of Ireland (PSI) is the statutory pharmacy regulator established to protect the health, safety, and wellbeing of the public. For internationally educated pharmacists who qualified outside the EU/EEA, entry into the Irish pharmacy workforce requires rigorous verification that their education, training, and clinical competence meet the standard expected of graduates from Irish pharmacy degree programs.

---

The Four-Stage TCQR Recognition Process

The TCQR framework is structured as a sequential four-stage pathway designed to evaluate qualifications objectively while safeguarding public health.

---

Path A versus Path B Allocation Criteria

Following the Stage 2 holistic assessment, the PSI TCQR Committee categorizes applications into one of two pathways based on identified curricular or clinical practice gaps:

Path A (Direct Equivalence or Targeted Adaptation)

Path A is reserved for candidates whose non-EU qualification and post-qualification experience demonstrate no substantial deficits when benchmarked against the Irish Level 9 Master of Pharmacy (MPharm) standard. Candidates allocated to Path A may proceed directly to registration or complete a specified period of adaptation or practical training without taking the full PSI Equivalence Examination.

Path B (Full Professional Equivalence Examination)

Path B is assigned when the TCQR Committee determines that substantial differences exist between the candidate's primary qualification and the Irish qualification standard, or where academic documentation alone cannot verify equivalent clinical practice standards. Path B candidates must sit and pass both components of the PSI Equivalence Examination (MCQ and OSCE) to demonstrate professional equivalence.

                    [ Stage 1: Documentation & English Language ]
                                         │
                                         ▼
                    [ Stage 2: Holistic Qualification Audit ]
                                         │
                  ┌──────────────────────┴──────────────────────┐
                  ▼                                             ▼
      [ Path A: Minor Gaps ]                        [ Path B: Substantial Gaps ]
                  │                                             │
                  ▼                                             ▼
     (Adaptation / Direct Entry)                  [ Stage 3: Equivalence Exam ]
                  │                                  (MCQ Part A/B + OSCE)
                  │                                             │
                  └──────────────────────┬──────────────────────┘
                                         ▼
                     [ Stage 4: PSI Pharmacist Registration ]

---

Structure and Delivery of the Equivalence Examination

The Stage 3 Equivalence Examination is held in Dublin in partnership with the RCSI University of Medicine and Health Sciences. The examination tests whether a candidate possesses the requisite knowledge, judgment, and practical skills of an entry-level Irish pharmacist. The exam comprises two distinct, compulsory components:

Component 1: Multiple Choice Question (MCQ) Examination

The MCQ component is delivered via computer-based testing and is partitioned into two distinct parts taken on the same examination day. PSI/RCSI does not publish the exact time allocation for each part; candidates receive examination-day logistics through the RCSI examination portal:

• Part A: Pharmaceutical Calculations
  Focuses exclusively on dosage calculations, millimoles, tonicity, infusion rates, serial dilutions, body surface area (BSA) estimations, and displacement values. Part A enforces a strict accuracy threshold, reflecting the zero-tolerance standard for dosing errors in Irish clinical practice.
• Part B: Applied Pharmaceutical Practice & Therapeutics
  Evaluates knowledge across Irish pharmacy law, ethics, over-the-counter (OTC) consultations, clinical therapeutics, disease state management, drug interactions, and Health Products Regulatory Authority (HPRA) drug safety guidelines.

Component 2: Objective Structured Clinical Examination (OSCE)

The OSCE evaluates practical, behavioral, and communication skills in simulated clinical scenarios. Per the PSI's published OSCE guidance, the examination consists of 12 stations in total — 6 live/interactive stations and 6 written stations, each lasting 7 minutes following a brief familiarisation period. At the live stations candidates interact with simulated patients, standard actors, and clinical assessors; the written stations require documented responses to clinical scenarios using supplied resources. Station domains include:

1. Patient Consultation & OTC Triage: History-taking, symptom assessment, and recommendation of non-prescription medicines or referral.
2. Prescription Validation & Error Spotting: Intercepting prescribing errors, contraindications, incorrect dosages, and legal irregularities under Irish prescription regulations.
3. Interprofessional Communication: Articulating drug therapy recommendations to general practitioners (GPs), hospital consultants, or nursing staff.
4. Patient Counseling & Device Demonstration: Educating patients on complex regimens, inhaler technique, insulin pens, or high-risk oral anticoagulants.
5. Health Promotion & Public Health Advice: Delivering evidence-based smoking cessation, vaccination counseling, or cardiovascular risk mitigation.

Independent Pass Requirement & Compensation Rules

Candidates must pass both the MCQ and OSCE components independently. There is no compensation allowed between MCQ Part A and Part B, nor can a high score in the MCQ offset a fail result in the OSCE. Each component must meet or exceed its specific cut-off score as determined by standard-setting methodology (such as the modified Angoff method for MCQ and borderline group method for OSCE).

---

Fee Schedule and Administrative Regulations

The PSI establishes a transparent fee structure for candidates undertaking Stage 3 assessments. Fees are subject to periodic review by the PSI Council:

All examination sittings take place at designated RCSI academic facilities in Dublin. Candidates who fail one or both components are permitted retake attempts in accordance with the PSI TCQR Examination Regulations, provided retakes occur within specified maximum timeframe windows (typically within 2 years of initial assessment entry).

---

Results Timeline and Registration Path

Following completion of the examination diet, official results are ratified by the PSI Board of Examiners and issued to candidates within 4 to 6 weeks. Upon receiving confirmation of a passing grade in both components:

1. The candidate receives formal written notification of successful TCQR Stage 3 completion.
2. The candidate becomes eligible to apply under Stage 4 for First-Time Registration on the PSI Register of Pharmacists.
3. The candidate must complete statutory declarations, submit character references, pay the initial registration fee, and demonstrate compliance with Continuing Professional Development (CPD) obligations overseen by the Irish Institute of Pharmacy (IIOP).
4. Once registered, the candidate receives a certificate of registration enabling legal practice as a pharmacist in Ireland.